Policy & Regulation
WuXi Biologics named in 2026 Dow Jones Best-in-Class World Index and Emerging Markets Index
13 May 2026 -

WuXi Biologics (2269.HK), a China-based global Contract Research, Development and Manufacturing Organisation (CRDMO), announced on Tuesday that, in recognition of its continued efforts and performance in advancing sustainability, the Company has been included in the 2026 Dow Jones Best-in-Class World Index (DJ BIC World) and the Dow Jones Best-in-Class Emerging Markets Index (DJ BIC Emerging Markets).

Through S&P Global's Corporate Sustainability Assessment (CSA), the DJ BIC World Index and the DJ BIC Emerging Markets Index are claimed to identify sustainability leaders that rank in the top 10 percent based on their long-term economic, environmental and social performance, selecting from the largest 2,500 global companies in the S&P Global Broad Market Index (BMI) and from the largest 800 companies across 20 emerging markets, respectively.

Based on the 2025 CSA, WuXi Biologics ranked among the top 1% globally within its industry, and was included in the S&P Global Sustainability Yearbook for the fourth consecutive year.

Login
Username:

Password: